Immune modulator therapy for microscopic colitis in a case series of 73 patients
Alimentary Pharmacology & Therapeutics2017Vol. 46(2), pp. 169–174
Citations Over TimeTop 10% of 2017 papers
Thomas G. Cotter, Amrit K. Kamboj, Stephen B. Hicks, William J. Tremaine, Edward V. Loftus, Darrell S. Pardi
Abstract
The majority of patients with active MC responded to thiopurines, methotrexate, or anti-TNF therapy. Larger controlled studies are required to confirm the efficacy and safety of these medications in MC.
Related Papers
- → Oral budesonide therapy improves quality of life in patients with collagenous colitis(2004)81 cited
- → Meta‐analysis: budesonide treatment for collagenous colitis(2004)27 cited
- → Budesonide in the Treatment of Collagenous Colitis(1998)34 cited
- → Use of budesonide in the treatment of microscopic colitis(2010)4 cited
- → Efficacy of budesonide in collagenous colitis(2014)1 cited